98 related articles for article (PubMed ID: 21336947)
1. No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update.
He T
Breast Cancer Res Treat; 2011 Jul; 128(2):589-91. PubMed ID: 21336947
[No Abstract] [Full Text] [Related]
2. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
McColgan P; Sharma P
Int J Cancer; 2009 Sep; 125(6):1473-8. PubMed ID: 19507256
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis.
Velho FM; Cohen CR; Santos KG; Silvello D; Martinelli N; Biolo A; Clausell N; Rohde LE
J Card Fail; 2011 Feb; 17(2):115-21. PubMed ID: 21300300
[TBL] [Abstract][Full Text] [Related]
4. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
6. Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results.
Roehe AV; Frazzon AP; Agnes G; Damin AP; Hartman AA; Graudenz MS
Breast Cancer Res Treat; 2007 Mar; 102(1):123-4. PubMed ID: 17260100
[No Abstract] [Full Text] [Related]
7. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
Wu XY; Chen MB; Wang LQ; Xu Y; Tan Y; Shen WX
Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
[No Abstract] [Full Text] [Related]
8. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK
PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797
[TBL] [Abstract][Full Text] [Related]
9. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women].
Shevchenko AV; Konenkov VI; Garbukov EIu; Stakheeva MN
Vopr Onkol; 2014; 60(5):630-5. PubMed ID: 25816670
[TBL] [Abstract][Full Text] [Related]
10. Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability.
Newby AC; Johnson JL
Circ Res; 2005 Nov; 97(10):958-60. PubMed ID: 16284186
[No Abstract] [Full Text] [Related]
11. No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.
Beeghly-Fadiel A; Cai Q; Lu W; Long J; Gao YT; Shu XO; Zheng W
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1324-7. PubMed ID: 19318431
[No Abstract] [Full Text] [Related]
12. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma.
Früh M; Zhou W; Zhai R; Su L; Heist RS; Wain JC; Nishioka NS; Lynch TJ; Shepherd FA; Christiani DC; Liu G
Br J Cancer; 2008 Feb; 98(4):689-92. PubMed ID: 18253117
[TBL] [Abstract][Full Text] [Related]
13. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse.
Ferrari MM; Rossi G; Biondi ML; Viganò P; Dell'utri C; Meschia M
Arch Gynecol Obstet; 2012 Jun; 285(6):1581-6. PubMed ID: 22210296
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
Tang LJ; Chen XF; Zhu M; Jiang JJ; Lu XB; Du YX; Wang B; Fang CF; Xue YS; Shen WF
Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894
[TBL] [Abstract][Full Text] [Related]
15. MMP1 and MMP3 polymorphisms in promoter regions and cancer.
Biondi ML; Turri O; Leviti S; Seminati R; Cecchini F; Bernini M; Ghilardi G; Guagnellini E
Clin Chem; 2000 Dec; 46(12):2023-4. PubMed ID: 11106348
[No Abstract] [Full Text] [Related]
16. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I
Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080
[TBL] [Abstract][Full Text] [Related]
17. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of Matrix Metalloproteinases Genes MMP1, MMP2, MMP3, and MMP7 and the Risk of Varicose Veins of Lower Extremities.
Shadrina AS; Smetanina MA; Sevost'yanova KS; Shevela AI; Seliverstov EI; Zakharova EA; Voronina EN; Ilyukhin EA; Zolotukhin IA; Kirienko AI; Filipenko ML
Bull Exp Biol Med; 2017 Sep; 163(5):650-654. PubMed ID: 28944430
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer].
Araki A; Hazama S; Oka M; Hinoda Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():229-32. PubMed ID: 14574887
[No Abstract] [Full Text] [Related]
20. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Lu Z; Cao Y; Wang Y; Zhang Q; Zhang X; Wang S; Li Y; Xie H; Jiao B; Zhang J
J Neurooncol; 2007 Oct; 85(1):65-73. PubMed ID: 17502998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
